Insider Transactions in Q2 2021 at Integra Lifesciences Holdings Corp (IART)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2021
|
Raymond G. Murphy Director |
SELL
Open market or private sale
|
Direct |
1,253
-2.69%
|
$83,951
$67.22 P/Share
|
|
Jun 01
2021
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,505
-7.81%
|
$102,340
$68.37 P/Share
|
|
May 14
2021
|
Stuart Essig Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
3,532
+0.39%
|
-
|
|
May 14
2021
|
Barbara B Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,956
+2.5%
|
-
|
|
May 14
2021
|
Shaundra Clay Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,020
+46.8%
|
-
|
|
May 14
2021
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,426
+3.6%
|
-
|
|
May 14
2021
|
Rhonda Germany Ballintyn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,956
+10.68%
|
-
|
|
May 14
2021
|
Raymond G. Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,426
+3.52%
|
-
|
|
May 14
2021
|
Donald E Morel Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,426
+3.15%
|
-
|
|
May 14
2021
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,896
+5.24%
|
-
|
|
May 13
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
57
-0.06%
|
$3,990
$70.65 P/Share
|
|
May 10
2021
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
5,335
-25.42%
|
$400,125
$75.0 P/Share
|
|
May 10
2021
|
Lisa Evoli EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,335
+20.27%
|
$261,415
$49.65 P/Share
|
|
Apr 16
2021
|
Glenn Coleman Executive Vice President & COO |
SELL
Open market or private sale
|
Direct |
25,658
-44.46%
|
$1,821,718
$71.5 P/Share
|
|
Apr 16
2021
|
Glenn Coleman Executive Vice President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,658
+30.78%
|
$487,502
$19.41 P/Share
|
|
Apr 14
2021
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
6,306
-20.42%
|
$441,420
$70.0 P/Share
|
|
Apr 14
2021
|
Lisa Evoli EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,225
+19.53%
|
$256,025
$49.96 P/Share
|
|
Apr 14
2021
|
Glenn Coleman Executive Vice President & COO |
SELL
Open market or private sale
|
Direct |
4,002
-11.1%
|
$280,140
$70.5 P/Share
|
|
Apr 09
2021
|
Glenn Coleman Executive Vice President & COO |
SELL
Open market or private sale
|
Direct |
12,500
-25.74%
|
$875,000
$70.0 P/Share
|
|
Apr 09
2021
|
Glenn Coleman Executive Vice President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+20.47%
|
$237,500
$19.41 P/Share
|